{"corpus_id":97106121,"paper_sha":"b6312778c9024d31fbc644575803ef62142162eb","doi":"10.1590/S0100-40422011000200023","arxiv_id":null,"pmid":null,"pmcid":null,"mag_id":2075437878,"dblp_id":null,"acl_id":null,"title":"Pharmaceutical use of galactomannans","year":2011,"publication_date":null,"venue":"","journal":{"name":"Química Nova","pages":"292-299","volume":"34"},"journal_issn":null,"journal_title":null,"publication_types":[],"pubmed_pub_types":null,"s2_fields_of_study":["Medicine","Chemistry"],"reference_count":0,"citation_count":46,"influential_citation_count":0,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":null,"chemicals":null,"comments_corrections":null,"source_flags":1,"s2_open_access_pdf_url":"https://www.scielo.br/j/qn/a/FvYvMS57GDjcGnLSNLH5qft/?lang=en&format=pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/b6312778c9024d31fbc644575803ef62142162eb","s2_open_access_license":"CCBYNC","s2_open_access_status":"GOLD","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"The pharmaceutical use of galactomannans from different sources, commercial and noncommercial, has been extensively studied over the past decade. Galactomannans show potential in the global trend towards the use of more plant-based products for ecological motives, and their production and application do not cause pollution or disturb the ecosystem. There is a variety of galactomannan sources and various pharmaceutical forms of application, such as tablets or capsules, hydrogels and films. Besides the simple use as inert excipient this polysaccharides play role in the modification of drug release, especially in colonic environmental, as a matrix or coating material.","claims":[{"public_id":"cl_e756e20348d9c6d6ef293a9f70f174da","status":"active","text":"A variety of galactomannan sources and pharmaceutical forms have been reported, including tablets, capsules, hydrogels, and films.","confidence":0.93,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_e756e20348d9c6d6ef293a9f70f174da"},{"public_id":"cl_43c2667a902d1d590e04e139d80661e6","status":"active","text":"Galactomannans are used not only as inert excipients but also to modify drug release, especially in colonic environments, as matrix or coating materials.","confidence":0.96,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_43c2667a902d1d590e04e139d80661e6"},{"public_id":"cl_dccdde7c138a11d6ce1b7bbc1d641b00","status":"active","text":"Galactomannans have been extensively studied for pharmaceutical use over the past decade.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_dccdde7c138a11d6ce1b7bbc1d641b00"}],"concepts":[{"public_id":"co_14cbbf7ee25d53a5be4c6ee6131fc5e4","status":"active","name":"pharmaceutical use","description":"Application of galactomannans in drug delivery and pharmaceutical formulation.","types":["application"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_14cbbf7ee25d53a5be4c6ee6131fc5e4"},{"public_id":"co_275c4d6e87c5d5935ba0bca3bdbf2e8a","status":"active","name":"commercial galactomannans","description":"Galactomannan materials available through commercial sources.","types":["material source"],"aliases":["commercial sources"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_275c4d6e87c5d5935ba0bca3bdbf2e8a"},{"public_id":"co_3bd3d4bf89ff5a507c813972c730a52f","status":"active","name":"matrix or coating material","description":"A formulation component used to form the bulk matrix of a dosage form or to coat its surface.","types":["excipient","formulation component"],"aliases":["matrix","coating material"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3bd3d4bf89ff5a507c813972c730a52f"},{"public_id":"co_3dcffb502831db94c72733560af5f7cd","status":"active","name":"galactomannans","description":"Plant-derived polysaccharides composed of a mannose backbone with galactose side chains, used in pharmaceutical formulations.","types":["polysaccharide","excipient"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3dcffb502831db94c72733560af5f7cd"},{"public_id":"co_9caa118fe271a32c5a483c63834ca97c","status":"active","name":"plant-based products","description":"Products derived from plants, highlighted here as a formulation trend.","types":["product category"],"aliases":["plant-derived products"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_9caa118fe271a32c5a483c63834ca97c"},{"public_id":"co_a7829c351f390965f1bfdb23d4bb90af","status":"active","name":"drug release modification","description":"Adjustment of the rate or site at which a drug is released from a formulation.","types":["drug delivery mechanism"],"aliases":["controlled release"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_a7829c351f390965f1bfdb23d4bb90af"},{"public_id":"co_b49af2d761b474cf2dafd79bc4096009","status":"active","name":"tablets or capsules","description":"Solid oral dosage forms mentioned as one way galactomannans are formulated.","types":["dosage form"],"aliases":["tablets","capsules"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_b49af2d761b474cf2dafd79bc4096009"},{"public_id":"co_c86c70cce9f15a9d9ef1dbff91eb0c7b","status":"active","name":"colonic environments","description":"The conditions present in the colon, where some galactomannan-based systems are intended to release drug.","types":["biological environment"],"aliases":["colonic environmental","colon"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c86c70cce9f15a9d9ef1dbff91eb0c7b"},{"public_id":"co_c9dff1fcaf18b9630a4a7acb9116519c","status":"active","name":"noncommercial galactomannans","description":"Galactomannan materials obtained from noncommercial or in-house sources.","types":["material source"],"aliases":["noncommercial sources"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c9dff1fcaf18b9630a4a7acb9116519c"},{"public_id":"co_d474df14c045a0db8ecb41abb51580cf","status":"active","name":"hydrogels and films","description":"Polymeric gel and thin-film formulations used as pharmaceutical delivery systems.","types":["dosage form"],"aliases":["hydrogels","films"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d474df14c045a0db8ecb41abb51580cf"}],"external_ids":{"DOI":"10.1590/S0100-40422011000200023","ArXiv":null,"PubMed":null,"PubMedCentral":null,"MAG":2075437878,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://www.scielo.br/j/qn/a/FvYvMS57GDjcGnLSNLH5qft/?lang=en&format=pdf","landing_url":"https://www.semanticscholar.org/paper/b6312778c9024d31fbc644575803ef62142162eb","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBYNC","status":"GOLD","reason":null},"reference_availability":{"status":"unknown","references_indexed":false,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":1},"paper_id":630597,"paper_uid":"25436394-9ff0-4515-a6b2-6238974ea4cd","canonical_identity":{"paper_id":630597,"paper_uid":"25436394-9ff0-4515-a6b2-6238974ea4cd","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/97106121"}